Concurrent trastuzumab and HER2/neu-specific vaccination in patients with metastatic breast cancer.
J. Clin. Oncol., Oct;27(28):4685-92 (2009)
Level of HER-2/neu protein expression in breast cancer may affect the development of endogenous HER-2/neu-specific immunity.
Mol. Cancer Ther., Mar;7(3):449-54 (2008)
Common adjuvant breast cancer therapies do not inhibit cancer vaccine induced T cell immunity.
Breast Cancer Res. Treat., Jan;113(1):95-100 (2009)
Kinetics of tumor-specific T-cell response development after active immunization in patients with HER-2/neu overexpressing cancers.
Clin. Immunol., Dec;125(3):275-80 (2007)